Literature DB >> 22172527

Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.

Abdenour Belkacemi1, Charles Ramassamy2.   

Abstract

Alzheimer's disease (AD) is a multifactorial disorder characterized by the presence of amyloid plaques and neurofibrillary tangles (NFTs). Rare early-onset forms of AD are associated with autosomal dominant mutations in the amyloid precursor protein gene, presenilin 1 gene, or presenilin 2 gene. The late-onset form of the disease (LOAD) is the most common form. The causes of LOAD are not yet clarified, but several environmental and genetic risk factors have been identified. Numerous studies have highlighted a role for free radical-mediated injury to brain regions of this illness. In addition, studies from mild cognitive impairment patients suggest that oxidative stress is an early event in the pathogenesis of AD. The associations between these markers of free radical damage and the pathogenic cascades involved in AD are complex. Over the past 2 decades, a number of mouse models have been created to recapitulate the major neuropathological hallmarks of AD, namely amyloid plaques and NFTs. These mice recapitulate many, although not all, of the key features of AD. Some strains of transgenic mice develop amyloid plaques, some accumulate NFTs, and some do both. Here we review the evidence for increased free radical-mediated damage to the brain with particular attention to the stage of the disease in various transgenic models of AD related to the amyloid-β cascade.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172527     DOI: 10.1016/j.freeradbiomed.2011.11.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.

Authors:  Patricia Martín-Maestro; Ricardo Gargini; George Perry; Jesús Avila; Vega García-Escudero
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

2.  Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.

Authors:  Michael D Hoos; Brenna M Richardson; Matthew W Foster; Angela Everhart; J Will Thompson; M Arthur Moseley; Carol A Colton
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

Review 3.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

4.  Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro.

Authors:  Amrutha Chilumuri; Mark Odell; Nathaniel G N Milton
Journal:  ACS Chem Neurosci       Date:  2013-09-09       Impact factor: 4.418

5.  Effects of Curculigoside on Memory Impairment and Bone Loss via Anti-Oxidative Character in APP/PS1 Mutated Transgenic Mice.

Authors:  Lu Zhao; Sha Liu; Yin Wang; Qiaoyan Zhang; Wenjuan Zhao; Zejian Wang; Ming Yin
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

6.  Oxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease.

Authors:  Sara Porcellotti; Francesca Fanelli; Anna Fracassi; Sara Sepe; Francesco Cecconi; Cinzia Bernardi; AnnaMaria Cimini; Maria Paola Cerù; Sandra Moreno
Journal:  Oxid Med Cell Longev       Date:  2015-04-20       Impact factor: 6.543

Review 7.  Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review.

Authors:  Xinhua Zhan; Boryana Stamova; Frank R Sharp
Journal:  Front Aging Neurosci       Date:  2018-02-22       Impact factor: 5.750

8.  Serum concentrations of vitamin E and carotenoids are altered in Alzheimer's disease: A case-control study.

Authors:  Kathryn Mullan; Michael A Williams; Chris R Cardwell; Bernadette McGuinness; Peter Passmore; Giuliana Silvestri; Jayne V Woodside; Gareth J McKay
Journal:  Alzheimers Dement (N Y)       Date:  2017-07-19

Review 9.  Deconstructing mitochondrial dysfunction in Alzheimer disease.

Authors:  Vega García-Escudero; Patricia Martín-Maestro; George Perry; Jesús Avila
Journal:  Oxid Med Cell Longev       Date:  2013-06-11       Impact factor: 6.543

10.  The Immp2l mutation causes age-dependent degeneration of cerebellar granule neurons prevented by antioxidant treatment.

Authors:  Chunlian Liu; Xue Li; Baisong Lu
Journal:  Aging Cell       Date:  2015-11-30       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.